Table 4.
Clinical Characteristics of Multiple Myeloma Patients with Different Light-Chain Types of AL Amyloidosis
| Lambda (N=35) |
Kappa (N=14) |
P | |
|---|---|---|---|
| Age≧65 (%) | 9 (25.7) | 4 (28.5) | 0.838 |
| Sex=Male (%) | 26 (74.2) | 8 (57.1) | 0.396 |
| Serious anemia (%) | 2 (5.7) | 5 (35.7) | 0.024 |
| Severe bone destruction (%) | 13 (37.1) | 6 (42.8) | 0.711 |
| Hypercalcemia (%) | 1 (2.8) | 2 (14.2) | 0.396 |
| Renal insufficiency (%) | 4 (11.4) | 7 (50.0) | 0.011 |
| Higher LDH (%) | 8 (22.8) | 5 (35.7) | 0.357 |
| Higher BMPC (%) | 14 (31.4) | 7 (50.0) | 0.523 |
| Severe hypoalbuminemia (%) | 16 (45.7) | 4 (28.5) | 0.435 |
| Alkaline phosphatase>187.5IU/L (%) | 3 (8.5) | 4 (28.5) | 0.071 |
| Brain natriuretic peptide≧700pg/mL (%) | 10 (28.5) | 9 (64.2) | 0.020 |
Note: The bold font represents statistical significance.
Abbreviations: LDH, lactate dehydrogenase; BMPC, bone marrow plasma cells.